Goldman turns cautious on major pharma names, sees select upside at Eli Lilly

Apr 12, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 11, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Mar 7, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 12, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 10, 2025 0
Apr 12, 2025 0
Apr 11, 2025 0
Apr 11, 2025 0
Apr 10, 2025 0
Apr 11, 2025 0
Apr 3, 2025 0
Or register with email
Mar 25, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
Feb 9, 2025 0
This site uses cookies. By continuing to browse the site you are agreeing to our use of cookies.